stars 1 stars 2 stars 3

AMAXA PHARMA has over 10 years' experience in the pharmaceutical market. We work in the fields of oncology, haematology, neurology and neonatology. We specialise in prescription and non-prescription medicines for the treatment of patients suffering from cancer, blood-related diseases, premature birth and other life-threatening or debilitating illnesses. Our core competencies are in the development and promotion of products in the CIS markets. Our team consists of experienced professionals with extensive knowledge of the development of medicine and the pharmaceutical industry. We maintain close ties with key opinion leaders throughout the research and development of our products and services. Our goal is to become a significant player in the Eastern Europe pharmaceutical market, as well as to provide a continuous supply of niche specialty medicines. The AMAXA management team has many years' experience in the commercialisation of pharmaceutical products. They provide the necessary expertise in the healthcare industry to establish successful partnerships that offer flexible and reliable services to international markets.

AMAXA PHARMA LTD Questions

The AMAXA PHARMA LTD annual revenue was $2.4 million in 2026.

Ted Maker is the VP Marketing of AMAXA PHARMA LTD.

16 people are employed at AMAXA PHARMA LTD.

AMAXA PHARMA LTD is based in London, Greater London.

The NAICS codes for AMAXA PHARMA LTD are [32, 3254, 325, 32541].

The SIC codes for AMAXA PHARMA LTD are [2834, 28, 283].

Top AMAXA PHARMA LTD Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users